2-((4-Ethyl-5-(thiophen-2-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(2-methoxy-5-methylphenyl)acetamide

Catalog No. :
ACONGN264
CAS No. :
572891-16-8
Molecular Formula :
C18H20N4O2S2
Molecular Weight :
388.52

IUPAC Name:2-((4-ethyl-5-(thiophen-2-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(2-methoxy-5-methylphenyl)acetamide

2-((4-Ethyl-5-(thiophen-2-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(2-methoxy-5-methylphenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((4-Ethyl-5-(thiophen-2-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(2-methoxy-5-methylphenyl)acetamide
IUPAC Name2-((4-ethyl-5-(thiophen-2-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(2-methoxy-5-methylphenyl)acetamide
MDL No.MFCD05151943
Molecular FormulaC18H20N4O2S2
Molecular Weight388.52
SMILESO=C(NC1=CC(C)=CC=C1OC)CSC2=NN=C(C3=CC=CS3)N2CC
InChI KeyXXOZVWPCTACIFA-UHFFFAOYSA-N
SynonymSALOR-INT L365866-1EA;2-([4-ETHYL-5-(2-THIENYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL)-N-(2-METHOXY-5-METHYLPHENYL)ACETAMIDE
CAS No.572891-16-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACONGN264 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOLYM432 route compound structure diagram
    ACOLYM43249742-89-4 In Stock
  4. Then
  5. ACONGN264 route product structure diagram
    ACONGN264572891-16-8
Inquiry

2. ACONGN264 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACONGN264 route product structure diagram
    ACONGN264572891-16-8
Inquiry

Comments (0)